Combating antimicrobial resistance during COVID
“While the world has spent the last two years laser-focused on the COVID pandemic, another public health threat is still lurking in the shadows: the rise of antibiotic-resistant bacteria. Antimicrobial resistance (AMR) has been recognized since the early 1900s, yet rigorous research over the past decade has illuminated the magnitude of the threat and its implications for future infection control. More than 35 thousand patients die from antibacterial resistance every year, and antibiotic-resistant infections exceed 2.8 million annually, according to a CDC report released prior to the COVID pandemic.”
Anne Meneghetti is an internal medicine physician and health care executive.
She shares her story and discusses her KevinMD article, “Combatting antimicrobial resistance during COVID: What clinicians need to know.“
Did you enjoy today’s episode?
Rate and review the show so more audiences can find The Podcast by KevinMD.
Subscribe on your favorite podcast app to get notified when a new episode comes out.
Click here to earn 1.0 AMA PRA Category 1 CME for this episode.
Also available in Category 1 CME bundles.
Powered by CMEfy – a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info